These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 16954334)

  • 1. Role of AMPKalpha2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle.
    Jørgensen SB; Treebak JT; Viollet B; Schjerling P; Vaulont S; Wojtaszewski JF; Richter EA
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E331-9. PubMed ID: 16954334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
    Jørgensen SB; Wojtaszewski JF; Viollet B; Andreelli F; Birk JB; Hellsten Y; Schjerling P; Vaulont S; Neufer PD; Richter EA; Pilegaard H
    FASEB J; 2005 Jul; 19(9):1146-8. PubMed ID: 15878932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of AMPKalpha2 enhances pyruvate dehydrogenase activity during exercise.
    Klein DK; Pilegaard H; Treebak JT; Jensen TE; Viollet B; Schjerling P; Wojtaszewski JF
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1242-9. PubMed ID: 17711995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice.
    Maarbjerg SJ; Jørgensen SB; Rose AJ; Jeppesen J; Jensen TE; Treebak JT; Birk JB; Schjerling P; Wojtaszewski JF; Richter EA
    Am J Physiol Endocrinol Metab; 2009 Oct; 297(4):E924-34. PubMed ID: 19654283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
    Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
    Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
    Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice.
    Goirand F; Solar M; Athea Y; Viollet B; Mateo P; Fortin D; Leclerc J; Hoerter J; Ventura-Clapier R; Garnier A
    J Physiol; 2007 Jun; 581(Pt 3):1163-71. PubMed ID: 17446219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
    Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    Jørgensen SB; Viollet B; Andreelli F; Frøsig C; Birk JB; Schjerling P; Vaulont S; Richter EA; Wojtaszewski JF
    J Biol Chem; 2004 Jan; 279(2):1070-9. PubMed ID: 14573616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
    Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MEF2A binding to the Glut4 promoter occurs via an AMPKα2-dependent mechanism.
    Gong H; Xie J; Zhang N; Yao L; Zhang Y
    Med Sci Sports Exerc; 2011 Aug; 43(8):1441-50. PubMed ID: 21233771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle.
    Kramer HF; Witczak CA; Fujii N; Jessen N; Taylor EB; Arnolds DE; Sakamoto K; Hirshman MF; Goodyear LJ
    Diabetes; 2006 Jul; 55(7):2067-76. PubMed ID: 16804077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle.
    Li J; Hu X; Selvakumar P; Russell RR; Cushman SW; Holman GD; Young LH
    Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E834-41. PubMed ID: 15265762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift.
    Röckl KS; Hirshman MF; Brandauer J; Fujii N; Witters LA; Goodyear LJ
    Diabetes; 2007 Aug; 56(8):2062-9. PubMed ID: 17513699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice.
    Thomson DM; Porter BB; Tall JH; Kim HJ; Barrow JR; Winder WW
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E196-202. PubMed ID: 16926377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP kinase is not required for the GLUT4 response to exercise and denervation in skeletal muscle.
    Holmes BF; Lang DB; Birnbaum MJ; Mu J; Dohm GL
    Am J Physiol Endocrinol Metab; 2004 Oct; 287(4):E739-43. PubMed ID: 15165992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC-1{alpha} is required for AICAR-induced expression of GLUT4 and mitochondrial proteins in mouse skeletal muscle.
    Leick L; Fentz J; Biensø RS; Knudsen JG; Jeppesen J; Kiens B; Wojtaszewski JF; Pilegaard H
    Am J Physiol Endocrinol Metab; 2010 Sep; 299(3):E456-65. PubMed ID: 20628026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic AICAR administration on the metabolic and contractile phenotypes of rat slow- and fast-twitch skeletal muscles.
    Bamford JA; Lopaschuk GD; MacLean IM; Reinhart ML; Dixon WT; Putman CT
    Can J Physiol Pharmacol; 2003 Nov; 81(11):1072-82. PubMed ID: 14719043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.